Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Literature
1.
2.
Marzec LN, Goscch KL, Chan PS et al (2015) Abstract 14902: the introduction of novel oral anticoagulants has improved overall oral anticoagulants rates in atrial fibrillation: insights from the NCDR PINNACLE Registry. Circulation
3.
Cyr L, Francis K (1992) Measures of clinical agreement for nominal and categorical data: the kappa coefficient. Comput Biol Med 22:239CrossRef
4.
Brais C, Larochelle J, Turgeon MH, Blais L, Farand P (2017) Predictors of direct oral anticoagulants utilization for thromboembolism prevention in atrial fibrillation. J Pharm Sci 20:8–14
5.
AbuDagga A, Stephenson J, Fu A-C, Kwong WJ, Tan H, Weintraub WS (2014) Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res 14:310CrossRef
6.
Desai NR, Krumme AA, Schneeweiss S, Shrank WH, Brill G, Pezalla EJ, Spettell CM, Brennan TA, Matlin OS, Avorn J, Choudhry NK (2014) Patterns of initiation of oral anticoagulants in patients with atrial fibrillation: quality and cost implications. Am J Med 127:1075–1082CrossRef
7.
Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L et al (2018) The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39:1330–1393CrossRef
8.
Desmaele S, Steurbaut S, Cornu P, Brouns R, Dupont AG (2016) Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients? Eur J Clin Pharmacol 72:1125–1134CrossRef
Metadata
Title
Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al.
Authors
Antonella Mameli
Paola Schirru
Mariagrazia Porru
Francesco Marongiu
Doris Barcellona
Publication date
01-01-2020
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-019-01960-4

Other articles of this Issue 1/2020

Journal of Thrombosis and Thrombolysis 1/2020 Go to the issue

BriefCommunication

A case of acute pancreatitis-induced microangiopathic hemolytic anemia with thrombocytopenia

Letter to the Editor

An unusual cause of acute ischemic stroke: Adult Onset Still’s Disease

OriginalPaper

Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis

BriefCommunication

Platelet reactivity in patients with chronic kidney disease and hemodialysis

OriginalPaper

Cancer-associated thromboembolism: antithrombotic management of hospitalized patients

OriginalPaper

Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits